Literature DB >> 16040297

Lack of alkaline phosphatase activity predicts meningioma recurrence.

Corinne Bouvier1, Agnès Liprandi, Carole Colin, Roch Giorgi, Benoit Quilichini, Philippe Metellus, Dominique Figarella-Branger.   

Abstract

Meningiomas usually are benign intracranial tumors. However, some recur despite gross total resection, invade surrounding structures, or, rarely, metastasize. Reduced expression of the nonspecific tissue-type alkaline phosphatase (Pal) has been reported in high-grade meningiomas. To search for a predictor for recurrence, we studied Pal expression by histoenzymology in a series of 54 meningiomas with gross total removal. Pal expression was mostly altered in grades II and III meningiomas (P = .000014) and meningiomas with high MIB-1 values (P = .001). Pal expression correlated with cytogenetic data (P = .000033) and with recurrence (P = .0064); all tumors that recurred had abnormal Pal expression (13/13). In univariate analysis, Pal expression was the only variable correlated with recurrence-free survival (P = .035). Histochemical detection of Pal is a useful, easy, and low-cost technique to predict recurrence in meningiomas.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16040297     DOI: 10.1309/482A-WA3U-8DJU-EXWU

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  4 in total

1.  Hyperdiploidy defines a distinct cytogenetic entity of meningiomas.

Authors:  Ralf Ketter; Yoo-Jin Kim; Simone Storck; Jörg Rahnenführer; Bernd F M Romeike; Wolf-Ingo Steudel; Klaus D Zang; Wolfram Henn
Journal:  J Neurooncol       Date:  2007-01-17       Impact factor: 4.130

2.  Histopathologic indicators of recurrence in meningiomas: correlation with clinical and genetic parameters.

Authors:  Yoo-Jin Kim; Ralf Ketter; Wolfram Henn; Klaus D Zang; Wolf-Ingo Steudel; Wolfgang Feiden
Journal:  Virchows Arch       Date:  2006-10-03       Impact factor: 4.064

3.  [Meningiomas: multiparametric approach for risk stratification and grading].

Authors:  K Yoo-Jin; Y Kim; N Bochem; R Ketter; W Henn; W Feiden
Journal:  Pathologe       Date:  2008-11       Impact factor: 1.011

Review 4.  Genetic/molecular alterations of meningiomas and the signaling pathways targeted.

Authors:  Patrícia Domingues; María González-Tablas; Álvaro Otero; Daniel Pascual; Laura Ruiz; David Miranda; Pablo Sousa; Jesús María Gonçalves; María Celeste Lopes; Alberto Orfao; María Dolores Tabernero
Journal:  Oncotarget       Date:  2015-05-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.